Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€5.09

€5.09

-0.490%
-0.025
-0.490%
€15.26

€15.26

 
20.09.24 / Stuttgart Stock Exchange WKN: A3DWPS / Symbol: KALA / Name: Kala Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€8.00
08.09.24
3.06%
buy
€13.55
19.08.24
-4.18%
buy
€16.55
17.05.24
-11.19%
buy
€19.50
02.04.24
-26.75%
buy
€13.96
01.04.24
-25.94%
buy
€20.23
17.11.23
3.20%
buy
Your prediction

Kala Pharmaceuticals Inc. Stock

Kala Pharmaceuticals Inc. shows a slight decrease today, losing -€0.025 (-0.490%) compared to yesterday.
Kala Pharmaceuticals Inc. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 15 € there is potential for a 194.7% increase which would mean more than doubling the current price of 5.09 € for Kala Pharmaceuticals Inc..
So far the community has only identified positive things for Kala Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Kala Pharmaceuticals Inc. in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Kala Pharmaceuticals Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Kala Pharmaceuticals Inc. -0.490% -5.037% -6.862% -47.526% -21.933% -96.104% -
Evolus Inc 0.690% -2.667% 13.178% 71.765% 61.326% 124.615% -
Ardelyx Inc. 0.300% -3.408% -0.145% 50.219% -4.879% 404.404% 17.629%
Coherus Bioscien. -8.550% -21.454% -17.981% -79.037% -69.796% -93.838% -95.280%

Comments

Prediction Buy
Perf. (%) -4.18%
Target price 13.548
Change
Ends at 19.08.25

KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Ratings data for KALA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -11.19%
Target price 16.551
Change
Ends at 17.05.25

KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $21.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for KALA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -26.75%
Target price 19.499
Change
Ends at 02.04.25

KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $22.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for KALA provided by MarketBeat
Show more